Virtus ETF Advisers »

Sana Biotechnology shares owned by Virtus ETF Advisers

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by Virtus ETF Advisers from 13F filings

Historical chart of Virtus ETF Advisers investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by Virtus ETF Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $95k 23k 4.08

More positions owned by Virtus ETF Advisers

Vertex Pharmaceuticals Incorporated (VRTX)
Regeneron Pharmaceuticals (REGN)
Burlington Stores (BURL)
Expedia Group Com New (EXPE)
Monolithic Power Systems (MPWR)
D.R. Horton (DHI)
Oxford Lane Cap Corp (OXLC)
Lennar Corp Cl A (LEN)
United Rentals (URI)
Celanese Corporation (CE)
MercadoLibre (MELI)
Prologis (PLD)
Rollins (ROL)
Gartner (IT)
Lam Research Corporation (LRCX)

View all positions for Virtus ETF Advisers

Top funds holding Sana Biotechnology

Flagship Ventures Management
Baillie Gifford & Co
Vanguard Group
T. Rowe Price Associates
Crestline Management
Alphabet
Millennium Management
Baker Bros. Advisors
Partner Fund Management
Jpmorgan Chase & Co
Massachusetts Financial Services
Omega Fund Management
Goldman Sachs Group
Charles Schwab Investment Management
Arrowpoint Asset Management

View all funds holding Sana Biotechnology